Fundz

LabGenius Appoints Dr. Angus Sinclair as Chief Scientific Officer

PRIVATEJun 04, 2025

Position

Chief Scientific Officer

Company

LabGenius Therapeutics

Angus Sinclair
angus.sinclair@labgeni.us
LondonBiotechnologyArtificial Intelligence

Description

LabGenius Therapeutics has announced the appointment of Dr. Angus Sinclair as Chief Scientific Officer. Dr Sinclair will leverage his extensive experience in drug discovery to lead LabGenius’ scientific strategy.

Quick answer

LabGenius Appoints Dr. Angus Sinclair as Chief Scientific Officer (June 4, 2025). LabGenius Therapeutics is based in London, England, United Kingdom.

Who is the new Chief Scientific Officer at LabGenius Therapeutics?
LabGenius Therapeutics named Angus Sinclair Chief Scientific Officer, announced June 4, 2025.
What did LabGenius Therapeutics announce on June 4, 2025?
LabGenius Therapeutics has announced the appointment of Dr. Angus Sinclair as Chief Scientific Officer. Dr Sinclair will leverage his extensive experience in drug discovery to lead LabGenius’ scientific strategy.
What does LabGenius Therapeutics do?
LabGenius is a drug discovery company combining machine learning and high-throughput experimentation to optimize complex therapeutic antibodies.
Where is LabGenius Therapeutics based?
LabGenius Therapeutics is based in London, England, United Kingdom.
Which similar companies made leadership changes around the same time?
Circle8 Group Inc (June 2, 2025), Spectral AI (May 30, 2025), SRX Global Inc. (June 11, 2025) and Zimmer (May 27, 2025) also announced leadership changes within 45 days of LabGenius Therapeutics.

Source: Fundz verified event record.

Other recent leadership changes in Biotechnology and Artificial Intelligence

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at LabGenius Therapeutics, and when

A new leader at LabGenius Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day LabGenius Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at LabGenius Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at LabGenius Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

LabGenius Therapeutics

Location

London, England, United Kingdom

About

LabGenius is a drug discovery company combining machine learning and high-throughput experimentation to optimize complex therapeutic antibodies. The company focuses on innovative designs, including multispecific antibodies. LabGenius aims to drive advancements in drug discovery and development processes.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment LabGenius Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Angus
Likely contact at this company
••••••••@••••••••

See Angus's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for LabGenius Therapeutics's next move

Learn about Strategic plan

LabGenius Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.